Published in Cell on February 22, 2008
Mapping and analysis of chromatin state dynamics in nine human cell types. Nature (2011) 24.37
Direct conversion of fibroblasts to functional neurons by defined factors. Nature (2010) 18.76
Dissecting direct reprogramming through integrative genomic analysis. Nature (2008) 16.47
Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell (2008) 16.38
Mediator and cohesin connect gene expression and chromatin architecture. Nature (2010) 14.34
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell (2009) 13.02
Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature (2008) 12.21
lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature (2011) 11.31
Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet (2008) 11.17
Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell (2008) 10.68
Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol (2009) 9.29
Direct cell reprogramming is a stochastic process amenable to acceleration. Nature (2009) 8.71
Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell (2009) 8.62
A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature (2009) 7.96
A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol (2008) 7.91
Nanog is the gateway to the pluripotent ground state. Cell (2009) 7.27
Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell (2012) 7.17
Control of the embryonic stem cell state. Cell (2011) 6.89
iPS cells produce viable mice through tetraploid complementation. Nature (2009) 6.51
Chromatin remodelling during development. Nature (2010) 5.86
A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell (2008) 5.83
A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature (2009) 5.46
Direct conversion of human fibroblasts to multilineage blood progenitors. Nature (2010) 5.35
Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell (2010) 5.13
Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A (2010) 5.00
Epigenetic reprogramming and induced pluripotency. Development (2009) 4.90
Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell (2008) 4.43
Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet (2009) 4.28
SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state. Genes Dev (2009) 4.09
Dynamic single-cell imaging of direct reprogramming reveals an early specifying event. Nat Biotechnol (2010) 3.98
Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell (2009) 3.92
H2AZ is enriched at polycomb complex target genes in ES cells and is necessary for lineage commitment. Cell (2008) 3.90
Regulating RNA polymerase pausing and transcription elongation in embryonic stem cells. Genes Dev (2011) 3.55
The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev (2010) 3.37
PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. Mol Cell (2012) 3.28
The transcriptional foundation of pluripotency. Development (2009) 3.21
Reprogramming factor expression initiates widespread targeted chromatin remodeling. Cell Stem Cell (2011) 3.16
Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J Cell Biol (2010) 3.16
Exit from pluripotency is gated by intracellular redistribution of the bHLH transcription factor Tfe3. Cell (2013) 3.15
Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal. Cell Stem Cell (2012) 3.03
Epigenetic modifications in pluripotent and differentiated cells. Nat Biotechnol (2010) 3.02
Systems biology of stem cell fate and cellular reprogramming. Nat Rev Mol Cell Biol (2009) 2.93
Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells. Cell Stem Cell (2012) 2.93
Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc Natl Acad Sci U S A (2009) 2.86
Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci U S A (2009) 2.80
Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic and induced pluripotent stem cells. Genes Dev (2009) 2.70
Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell (2013) 2.69
Open chromatin in pluripotency and reprogramming. Nat Rev Mol Cell Biol (2011) 2.69
Direct lineage conversions: unnatural but useful? Nat Biotechnol (2011) 2.69
microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J Cell Biol (2010) 2.57
Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators. Nat Cell Biol (2010) 2.55
Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration. Nat Rev Mol Cell Biol (2011) 2.52
Transgenic mice with defined combinations of drug-inducible reprogramming factors. Nat Biotechnol (2009) 2.46
MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev (2009) 2.44
Epigenetic choreographers of neurogenesis in the adult mammalian brain. Nat Neurosci (2010) 2.39
Uncovering early response of gene regulatory networks in ESCs by systematic induction of transcription factors. Cell Stem Cell (2009) 2.32
Role for Dpy-30 in ES cell-fate specification by regulation of H3K4 methylation within bivalent domains. Cell (2011) 2.30
A DNA repair complex functions as an Oct4/Sox2 coactivator in embryonic stem cells. Cell (2011) 2.29
esBAF facilitates pluripotency by conditioning the genome for LIF/STAT3 signalling and by regulating polycomb function. Nat Cell Biol (2011) 2.29
Histone h3 lysine 56 acetylation is linked to the core transcriptional network in human embryonic stem cells. Mol Cell (2009) 2.27
Chromatin connectivity maps reveal dynamic promoter-enhancer long-range associations. Nature (2013) 2.25
Mechanisms and models of somatic cell reprogramming. Nat Rev Genet (2013) 2.09
Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Res (2010) 2.04
Differentiation therapy of leukemia: 3 decades of development. Blood (2009) 2.02
Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype. Cell Stem Cell (2009) 2.00
Control of embryonic stem cell lineage commitment by core promoter factor, TAF3. Cell (2011) 2.00
Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc (2008) 1.98
Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proc Natl Acad Sci U S A (2011) 1.97
Genes for embryo development are packaged in blocks of multivalent chromatin in zebrafish sperm. Genome Res (2011) 1.94
Pluripotency in the embryo and in culture. Cold Spring Harb Perspect Biol (2012) 1.93
E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming. EMBO Rep (2011) 1.93
Hierarchical mechanisms for direct reprogramming of fibroblasts to neurons. Cell (2013) 1.92
Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming. Oncogene (2012) 1.85
A central role for TFIID in the pluripotent transcription circuitry. Nature (2013) 1.82
EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. Genes Dev (2010) 1.81
Polycomb associates genome-wide with a specific RNA polymerase II variant, and regulates metabolic genes in ESCs. Cell Stem Cell (2012) 1.80
Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels. Proc Natl Acad Sci U S A (2012) 1.79
Induced neuronal cells: how to make and define a neuron. Cell Stem Cell (2011) 1.77
Roles of Krüpel-like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim Biophys Sin (Shanghai) (2008) 1.76
A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients. Blood (2009) 1.74
The role of miRNAs in regulating gene expression networks. J Mol Biol (2013) 1.74
Upping the ante: recent advances in direct reprogramming. Mol Ther (2009) 1.73
Induced pluripotent stem cells: developmental biology to regenerative medicine. Nat Rev Cardiol (2010) 1.71
FOXO1 is an essential regulator of pluripotency in human embryonic stem cells. Nat Cell Biol (2011) 1.70
Single-cell analysis reveals that expression of nanog is biallelic and equally variable as that of other pluripotency factors in mouse ESCs. Cell Stem Cell (2013) 1.67
Nuclear actin polymerization is required for transcriptional reprogramming of Oct4 by oocytes. Genes Dev (2011) 1.67
Satb1 and Satb2 regulate embryonic stem cell differentiation and Nanog expression. Genes Dev (2009) 1.67
Genome-wide analysis of mRNA targets for Caenorhabditis elegans FBF, a conserved stem cell regulator. Proc Natl Acad Sci U S A (2010) 1.66
Distinct histone modifications in stem cell lines and tissue lineages from the early mouse embryo. Proc Natl Acad Sci U S A (2010) 1.64
Dynamic regulation of alternative splicing and chromatin structure in Drosophila gonads revealed by RNA-seq. Cell Res (2010) 1.64
p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells. PLoS Biol (2012) 1.63
mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells. Proc Natl Acad Sci U S A (2009) 1.63
Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc (2009) 1.62
Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells. J Exp Med (2010) 1.60
Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming. J Biol Chem (2010) 1.59
The transcriptomes of two heritable cell types illuminate the circuit governing their differentiation. PLoS Genet (2010) 1.59
Maintaining embryonic stem cell pluripotency with Wnt signaling. Development (2011) 1.57
Tracking adult stem cells. EMBO Rep (2011) 1.56
Replication timing as an epigenetic mark. Epigenetics (2009) 1.53
OCT4 establishes and maintains nucleosome-depleted regions that provide additional layers of epigenetic regulation of its target genes. Proc Natl Acad Sci U S A (2011) 1.51
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature (2007) 65.18
A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell (2006) 48.80
Core transcriptional regulatory circuitry in human embryonic stem cells. Cell (2005) 34.93
Generation of germline-competent induced pluripotent stem cells. Nature (2007) 32.77
Reprogramming of human somatic cells to pluripotency with defined factors. Nature (2007) 30.84
Establishment in culture of pluripotential cells from mouse embryos. Nature (1981) 30.49
MicroRNAs modulate hematopoietic lineage differentiation. Science (2003) 30.05
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature (2007) 28.24
Control of developmental regulators by Polycomb in human embryonic stem cells. Cell (2006) 28.21
Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature (2006) 25.90
DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell (1999) 25.75
A chromatin landmark and transcription initiation at most promoters in human cells. Cell (2007) 23.41
Viable offspring derived from fetal and adult mammalian cells. Nature (1997) 22.46
Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell (1987) 22.17
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol (2007) 21.93
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell (2007) 21.58
The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet (2006) 20.76
Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell (2003) 20.16
Pluripotency of mesenchymal stem cells derived from adult marrow. Nature (2002) 19.57
Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell (1998) 19.05
Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A (1981) 18.96
MicroRNA-directed cleavage of HOXB8 mRNA. Science (2004) 18.33
The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell (2003) 17.72
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet (2005) 17.07
Dicer is essential for mouse development. Nat Genet (2003) 15.87
Network motifs: theory and experimental approaches. Nat Rev Genet (2007) 15.04
New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature (2007) 13.54
Embryonic stem cell-specific MicroRNAs. Dev Cell (2003) 13.05
Nanog safeguards pluripotency and mediates germline development. Nature (2007) 13.01
Chromatin signatures of pluripotent cell lines. Nat Cell Biol (2006) 12.88
Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell (2008) 12.29
Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev (2005) 12.15
Genome regulation by polycomb and trithorax proteins. Cell (2007) 11.96
Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature (2007) 11.72
Dissecting self-renewal in stem cells with RNA interference. Nature (2006) 11.66
Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell (2005) 9.84
Genomic targets of the human c-Myc protein. Genes Dev (2003) 9.67
Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol (2007) 9.67
A protein interaction network for pluripotency of embryonic stem cells. Nature (2006) 9.63
DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet (2007) 9.25
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol (2007) 9.04
Human embryonic stem cells express a unique set of microRNAs. Dev Biol (2004) 8.87
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature (2004) 8.87
c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell (2007) 8.46
Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature (2004) 8.36
Characterization of Dicer-deficient murine embryonic stem cells. Proc Natl Acad Sci U S A (2005) 8.35
The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc Natl Acad Sci U S A (2005) 8.33
Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature (1988) 7.61
Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells (2007) 7.57
Genetic and epigenetic regulators of pluripotency. Cell (2007) 7.47
A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci U S A (2003) 7.30
Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature (2002) 7.28
Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature (2003) 6.92
Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells (2005) 6.72
Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol (2007) 6.69
Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell (2007) 6.62
A histone H3 lysine 27 demethylase regulates animal posterior development. Nature (2007) 6.57
Changing potency by spontaneous fusion. Nature (2002) 6.46
Embryonic stem cells alone are able to support fetal development in the mouse. Development (1990) 6.37
Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature (2003) 6.35
Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Nat Cell Biol (2007) 6.30
Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science (2005) 6.14
MicroRNA-responsive 'sensor' transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression. Nat Genet (2004) 6.11
Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev (2007) 5.79
Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc Natl Acad Sci U S A (2001) 5.76
Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol (2001) 5.42
Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell (2007) 5.29
G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat Cell Biol (2006) 5.16
Plasticity of adult stem cells. Cell (2004) 5.13
Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell (2007) 4.94
Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell (1992) 4.85
Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell (2002) 4.56
Non-transcriptional control of DNA replication by c-Myc. Nature (2007) 4.55
De novo methylation and expression of retroviral genomes during mouse embryogenesis. Nature (1982) 4.42
Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene (2004) 4.40
Nanog promotes transfer of pluripotency after cell fusion. Nature (2006) 4.38
Long-term proliferation of mouse primordial germ cells in culture. Nature (1992) 4.31
Pluripotency of spermatogonial stem cells from adult mouse testis. Nature (2006) 4.29
Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature (2002) 4.16
A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell (1990) 3.97
Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol (2005) 3.97
Generation of pluripotent stem cells from neonatal mouse testis. Cell (2004) 3.95
The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development. Nature (2005) 3.78
IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature (2007) 3.74
Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. J Biol Chem (2004) 3.73
Nuclear reprogramming and pluripotency. Nature (2006) 3.68
Oct4 distribution and level in mouse clones: consequences for pluripotency. Genes Dev (2002) 3.52
The expression profile of microRNAs in mouse embryos. Nucleic Acids Res (2006) 3.49
Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. Development (2003) 3.22
Generalized potential of adult neural stem cells. Science (2000) 3.15
Core transcriptional regulatory circuitry in human hepatocytes. Mol Syst Biol (2006) 3.15
Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human. Dev Dyn (2004) 3.13
Reprogramming efficiency following somatic cell nuclear transfer is influenced by the differentiation and methylation state of the donor nucleus. Stem Cells (2006) 3.07
Generation of functional multipotent adult stem cells from GPR125+ germline progenitors. Nature (2007) 3.01
Developmental reprogramming after chromosome transfer into mitotic mouse zygotes. Nature (2007) 2.92
Notch promotes neural lineage entry by pluripotent embryonic stem cells. PLoS Biol (2006) 2.91
A common set of gene regulatory networks links metabolism and growth inhibition. Mol Cell (2004) 3.37
Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects. Am J Physiol Gastrointest Liver Physiol (2009) 1.91
Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells. Mol Cell Biol (2005) 1.81
In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates. J Pharmacol Exp Ther (2003) 1.70
Tissue engineering--a shifting paradigm. Burns (2002) 1.38
Experimental evidence of competitive release in sympatric carnivores. Biol Lett (2008) 1.28
Behavioral and biochemical investigations of bupropion metabolites. Eur J Pharmacol (2003) 1.25
Antibodies targeted to TRAIL receptor-2 and ErbB-2 synergize in vivo and induce an antitumor immune response. Proc Natl Acad Sci U S A (2008) 1.07
Ten years of genetics and genomics: what have we achieved and where are we heading? Nat Rev Genet (2010) 0.93
A p⁴ report: effect of curriculum innovation on residency applications and match performance. Fam Med (2011) 0.89
Plasma cell-free DNA as an indicator of severity of injury in burn patients. Clin Chem Lab Med (2006) 0.88
Self-reported racial discrimination, response to unfair treatment, and coronary calcification in asymptomatic adults--the North Texas Healthy Heart study. BMC Public Health (2010) 0.88
Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor models. J Nucl Med (2011) 0.87
Prevalence rate of myopia in schoolchildren in rural Mongolia. Optom Vis Sci (2006) 0.87
S(+)- and R(-)N-methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) as discriminative stimuli: effect of cocaine. Pharmacol Biochem Behav (2005) 0.86
Comparison of the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) and cocaine: asymmetric generalization. Drug Alcohol Depend (2004) 0.85
Small field of view imaging using wavelet encoding with 2 dimensional RF pulses and gradient echo: phantom results. MAGMA (2009) 0.84
Injured workers' construction of expectations of return to work with sub-acute back pain: the role of perceived uncertainty. J Occup Rehabil (2012) 0.84
Peripheral vascular adaptation and orthostatic tolerance in Fontan physiology. Circulation (2009) 0.83
Central stimulants as discriminative stimuli. Asymmetric generalization between (-)ephedrine and S(+)methamphetamine. Pharmacol Biochem Behav (2002) 0.83
Levels of acculturation and effect on glycemic control in Mexicans and Mexican Americans with type 2 diabetes. Postgrad Med (2011) 0.82
Learner-directed intentional diversification: the experience of three P4 programs. Fam Med (2011) 0.81
Effect of 8-hydroxy-2-(N,N-di-n-propylamino)tetralin and MDMA on the discriminative stimulus effects of the classical hallucinogen DOM in rats. Pharmacol Biochem Behav (2008) 0.80
Effect of PMA optical isomers and 4-MTA in PMMA-trained rats. Pharmacol Biochem Behav (2002) 0.79
N-Methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA) and N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) produce non-identical discriminative stimuli in rats. Pharmacol Biochem Behav (2007) 0.78
The role of adjuvant radiation therapy in the management of high-grade gliomas. Neurosurg Clin N Am (2012) 0.77
alpha-Ethyltryptamine (alpha-ET) as a discriminative stimulus in rats. Pharmacol Biochem Behav (2006) 0.77
Modulation of the stimulus effects of (+)amphetamine by the 5-HT6 antagonist MS-245. Pharmacol Biochem Behav (2004) 0.77
Facing The World in Vietnam: Feedback From Trainees on the Educational Value of Surgical Missions to Help Patients With Craniofacial Deformities. J Craniofac Surg (2016) 0.76
Beta-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. J Med Chem (2004) 0.76
Pharmacological properties and discriminative stimulus effects of a novel and selective 5-HT2 receptor agonist AL-38022A [(S)-2-(8,9-dihydro-7H-pyrano[2,3-g]indazol-1-yl)-1-methylethylamine]. Pharmacol Biochem Behav (2008) 0.76
Effect of 1-(3,4-methylenedioxyphenyl)-2-aminopropane and its optical isomers in PMMA-trained rats. Pharmacol Biochem Behav (2002) 0.76
MD-354 selectively antagonizes the antinociceptive effects of (-)nicotine in the mouse tail-flick assay. Psychopharmacology (Berl) (2010) 0.76
Comment on "Age and evolution of the Grand Canyon revealed by U-Pb dating of water table-type speleothems". Science (2008) 0.75
Stimulus effects of three sulfur-containing psychoactive agents. Pharmacol Biochem Behav (2004) 0.75
Use of antimicrobials. Vet Rec (2009) 0.75
Complications of facial fillers: resource implications for NHS hospitals. BMJ Case Rep (2013) 0.75
The 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats. Pharmacol Biochem Behav (2007) 0.75
Further characterization of the stimulus properties of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline. Pharmacol Biochem Behav (2002) 0.75
6-(2-Phenylethyl)nicotine: a novel nicotinic cholinergic receptor ligand. Bioorg Med Chem Lett (2005) 0.75
(-)6-n-Propylnicotine antagonizes the antinociceptive effects of (-)nicotine. Bioorg Med Chem Lett (2002) 0.75
Digital photography. Compend Contin Educ Dent (2003) 0.75
Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigations. Eur J Pharmacol (2002) 0.75
Dynamic surface activity of biological fluids, ophthalmic solutions and nanostructures. Adv Exp Med Biol (2002) 0.75
The Development of the World Anti-Doping Code. Med Sport Sci (2017) 0.75
Ten into one can go: gaining educational capacity through large group teaching in general practice. Educ Prim Care (2011) 0.75
Cecal volvulus in two African green monkeys (Cercopithecus athiops sabeus). Comp Med (2004) 0.75
Wavelet-encoding gradient-echo imaging sequence using real-time de-noising method for acquisition time reduction. MAGMA (2010) 0.75
Scope of Practice Among Recent Family Medicine Residency Graduates. Fam Med (2017) 0.75
Features of sentinel lymph nodes for melanoma may lead to re-diagnosis of the cutaneous primary: an unusual case and review of literature. Virchows Arch (2004) 0.75
Preferences for the white female nasal supratip break. Ann Plast Surg (2012) 0.75